Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01840722 · ClinicalTrials.gov registry record · NA

Brief Intervention for Rural Women at High Risk for HIV/HCV

A NA study, sponsored by Michele Staton.

Completed
Registry status
NA
Development phase
400
Enrollment target

NCT01840722 is a NA study that has completed, run by Michele Staton. The registered enrollment target is 400 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01840722, a NA study, has completed, sponsored by Michele Staton.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target

Study Summary

The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the health, risk behaviors, and service utilization of a vulnerable and understudied group of women during a time of emerging and significant public health risk in a rural Appalachian setting. Successful completion of the aims of this project will advance the delivery of a low-cost, potentially high impact intervention with implications for a number of other real world settings (such as criminal justice venues) where other disadvantaged high-risk drug users can be identified and targeted for intervention.

Interventions

  • OTHER MI-based HIV Risk Reduction

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2012-12
Est. Completion 2019-05
Phase NA

Sponsor

Michele Staton

5 total trials

What the Registry Record Tells You About NCT01840722

The ClinicalTrials.gov registry entry for NCT01840722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michele Staton, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which MI-based HIV Risk Reduction is the first listed.

NCT01840722 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01840722 about?

NCT01840722 is a clinical study titled "Brief Intervention for Rural Women at High Risk for HIV/HCV". The overall aim of this study is to reduce risk behaviors and increase health and behavioral health service utilization among disadvantaged, drug-using rural women at high risk for HIV and HCV. This project has potential to make a significant contribution to science by providing knowledge about the ...

What is the current status of trial NCT01840722?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2012-12. Estimated completion is 2019-05.

What interventions are being tested in trial NCT01840722?

The interventions under investigation include: MI-based HIV Risk Reduction (OTHER).

Who is sponsoring clinical trial NCT01840722?

This trial is sponsored by Michele Staton, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.